<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Cardiovasc Disord</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Cardiovasc Disord</journal-id>
      <journal-title-group>
        <journal-title>BMC Cardiovascular Disorders</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2261</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25618133</article-id>
      <article-id pub-id-type="pmc">4407327</article-id>
      <article-id pub-id-type="publisher-id">850</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2261-15-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Noncompaction cardiomyopathy: a substrate for a thromboembolic event</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Tavares de Melo</surname>
            <given-names>Marcelo Dantas</given-names>
          </name>
          <address>
            <email>marcelo_dtm@yahoo.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ara&#xFA;jo Filho</surname>
            <given-names>Jos&#xE9; Arimateia Batista de</given-names>
          </name>
          <address>
            <email>ariaraujocg@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Parga Filho</surname>
            <given-names>Jose Rodrigues</given-names>
          </name>
          <address>
            <email>parga@incor.usp.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Lima</surname>
            <given-names>Camila Rocon</given-names>
          </name>
          <address>
            <email>camilarocon@yahoo.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mady</surname>
            <given-names>Charles</given-names>
          </name>
          <address>
            <email>charles.mady@incor.usp.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kalil-Filho</surname>
            <given-names>Roberto</given-names>
          </name>
          <address>
            <email>kalil@uol.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salemi</surname>
            <given-names>Vera Maria Cury</given-names>
          </name>
          <address>
            <email>verasalemi@uol.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Heart Institute (InCor) do Hospital das Cl&#xED;nicas da Faculdade de Medicina da Universidade de S&#xE3;o Paulo, S&#xE3;o Paulo, Brazil </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>1</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>24</day>
        <month>1</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>7</elocation-id>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>8</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Tavares de Melo et al.; licensee BioMed Central. 2015</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Noncompaction cardiomyopathy (NCC) is a rare genetic cardiomyopathy characterized by a thin, compacted epicardial layer and an extensive noncompacted endocardial layer. The clinical manifestations of this disease include ventricular arrhythmia, heart failure, and systemic thromboembolism.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 43-year-old male was anticoagulated by pulmonary thromboembolism for 1&#xA0;year when he developed progressive dyspnea. Cardiovascular magnetic resonance imaging showed severe biventricular trabeculation with an ejection fraction of 15%, ratio of maximum noncompacted/compacted diastolic myocardial thickness of 3.2 and the presence of exuberant biventricular apical thrombus.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Still under discussion is the issue of which patients and when they should be anticoagulated. It is generally recommended to those presenting ventricular systolic dysfunction, antecedent of systemic embolism, presence of cardiac thrombus and atrial fibrillation. In clinical practice the patients with NCC and ventricular dysfunction have been given oral anticoagulation, although there are no clinical trials showing the real safety and benefit of this treatment.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/1471-2261-15-7) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Cardiomyopathy</kwd>
        <kwd>Echocardiography</kwd>
        <kwd>Magnetic resonance</kwd>
        <kwd>Noncompaction</kwd>
        <kwd>Thromboembolism</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>According to the American Heart Association, noncompaction cardiomyopathy (NCC) is a genetic disorder [<xref ref-type="bibr" rid="CR1">1</xref>] characterized by intrauterine arrest of the process of myocardial compaction that starts at the 8th week of gestation. Clinical manifestations include ventricular arrhythmia, heart failure, and systemic thromboembolism, especially encephalic. Ventricular hypertrabeculation is believed to be an anatomical substrate for the formation of thrombi. The literature shows an important variation in the incidence of embolic events in NCC between 0% and 38%, with few references to pulmonary thromboembolism [<xref ref-type="bibr" rid="CR2">2</xref>]. Yousef <italic>et al.</italic> found it in 7% of patients [<xref ref-type="bibr" rid="CR3">3</xref>]. The main limitation of these findings is the small number of patients in the studies.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 43-year-old male, obese, former-smoker patient was suffering from gout and had been anticoagulated by pulmonary thromboembolism for 1&#xA0;year when he developed progressive dyspnea without anginal complaints. He was directed to a tertiary hospital for investigation of heart failure. Through echocardiographic evaluation, severe biventricular diffuse systolic dysfunction with suspicion of noncompacted cardiomyopathy was identified, even though such a hypothesis could not be confirmed [Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>]. Cardiovascular magnetic resonance imaging (CMRI) showed severe biventricular trabeculation with an ejection fraction of 15%, ratio of maximum noncompacted/compacted diastolic myocardial thickness of 3.2 and the presence of exuberant biventricular apical thrombus [Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>]. CMRI disclosed transmural late gadolinium enhancement at 2/17 segments (mid-anteroseptal and apical septal). Coronary computed tomography angiogram showed a calcified nonobstructive plaque in the proximal left anterior descending coronary artery [Figure&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>].<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Echocardiographic images showing severe left ventricular systolic dysfunction (A) and a grade 2 diastolic dysfunction pattern (B to D).</bold>
</p></caption><graphic xlink:href="12872_2014_850_Fig1_HTML" id="d30e330"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Cardiovascular magnetic resonance short axis cine images showing left ventricular wall and trabeculation, with maximum non-compacted to compacted thickness ratio of 3.2 (normal&#x2009;&lt;&#x2009;2.3) (A); delayed enhancement long-axis five-chamber view showing left ventricular apical thrombus (B); multiple long-axis four-chambers disclosing biventricular thrombus (C); multiple short-axis two-chambers illustrating the same biventricular thrombus (D).</bold> LV (left ventricle).</p></caption><graphic xlink:href="12872_2014_850_Fig2_HTML" id="d30e342"/></fig><fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Coronary computed tomography angiogram showing a calcified nonobstructive plaque in the proximal left anterior descending coronary artery.</bold>
</p></caption><graphic xlink:href="12872_2014_850_Fig3_HTML" id="d30e355"/></fig></p>
      <p>In 2008, according to Fazio <italic>et al.</italic>, NCC does not present thromboembolic risk and there is no indication for anticoagulation [<xref ref-type="bibr" rid="CR4">4</xref>]. On the other hand, nowadays, the indication for anticoagulation treatment in NCC is still debatable. Almeida <italic>et al.</italic> recommended anticoagulation only in cases of left ventricular dilation and dysfunction or with previous embolic events [<xref ref-type="bibr" rid="CR5">5</xref>]. Recently, St&#xF6;llberger and Finsterer stated that thrombi may also develop in patients with NCC even with preserved systolic function [<xref ref-type="bibr" rid="CR6">6</xref>]. It is generally recommended to those presenting ventricular systolic dysfunction, antecedent of systemic embolism, presence of cardiac thrombus and atrial fibrillation [<xref ref-type="bibr" rid="CR7">7</xref>]. CMRI plays a crucial role in the diagnosis of left ventricular noncompaction, especially for its accuracy in detecting ventricular thrombi. No prospective study demonstrates the benefits of anticoagulation in NCC patients, which generates uncertainty and insecurity, because there are reports of patients without ventricular dysfunction or atrial fibrillation who have suffered a systemic thromboembolism.</p>
    </sec>
    <sec id="Sec3" sec-type="conclusions">
      <title>Conclusion</title>
      <p>This case report presents a patient with severe biventricular dysfunction in sinus rhythm, with previous pulmonary thromboembolism and biventricular thrombi. He presents a formal indication for anticoagulation. On the other hand, more studies are necessary to clarify this approach for patients presenting NCC with ventricular dysfunction in sinus rhythm.</p>
    </sec>
    <sec id="Sec4">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Electronic supplementary material</title>
      <sec id="Sec5">
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12872_2014_850_MOESM1_ESM.zip">
            <caption>
              <p>Additional file 1:
<bold>Four-chamber view cine steady state free precession cardiac MRI.</bold> The left ventricle has increased diastolic volume and severe ventricular dysfunction. (ZIP 4 MB)</p>
            </caption>
          </media>
        </supplementary-material>
      </sec>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>CMRI</term>
          <def>
            <p>Cardiovascular magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>NCC</term>
          <def>
            <p>Noncompaction cardiomyopathy.</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>MDTM: diagnosed and wrote the paper. JABAF: performed and analyzed the resonance magnetic imaging examination. JRPF: discussed the MRI diagnosis and reviewed the paper. CRL: wrote the paper. CM: reviewed the paper. RKF: reviewed the paper. VMCS: performed the echocardiographic exam and wrote the paper. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Grant</title>
      <p>processo n&#xBA; 2009/17146-2, Funda&#xE7;&#xE3;o de Amparo &#xE0; Pesquisa do Estado de S&#xE3;o Paulo (FAPESP).</p>
      <p>This grant helped us to fund the cardiac exams.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maron</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Towbin</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Thiene</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Antzelevitch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Corrado</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Arnett</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention</article-title>
          <source>Circulation</source>
          <year>2006</year>
          <volume>113</volume>
          <issue>14</issue>
          <fpage>1807</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.174287</pub-id>
          <pub-id pub-id-type="pmid">16567565</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oechslin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Jenni</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity</article-title>
          <source>Eur Heart J</source>
          <year>2011</year>
          <volume>32</volume>
          <issue>12</issue>
          <fpage>1446</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="doi">10.1093/eurheartj/ehq508</pub-id>
          <pub-id pub-id-type="pmid">21285074</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yousef</surname>
              <given-names>ZR</given-names>
            </name>
            <name>
              <surname>Foley</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Khadjooi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chalil</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sandman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mohammed</surname>
              <given-names>NU</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Left ventricular non-compaction: clinical features and cardiovascular magnetic resonance imaging</article-title>
          <source>BMC Cardiovasc Disord</source>
          <year>2009</year>
          <volume>9</volume>
          <fpage>37</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2261-9-37</pub-id>
          <pub-id pub-id-type="pmid">19664240</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fazio</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Corrado</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zachara</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rapezzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sulafa</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Sutera</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Anticoagulant drugs in noncompaction: a mandatory therapy?</article-title>
          <source>J Cardiovasc Med (Hagerstown)</source>
          <year>2008</year>
          <volume>9</volume>
          <issue>11</issue>
          <fpage>1095</fpage>
          <lpage>7.5</lpage>
          <pub-id pub-id-type="doi">10.2459/JCM.0b013e328308da04</pub-id>
          <pub-id pub-id-type="pmid">18852579</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Almeida</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>Non-compaction cardiomyopathy</article-title>
          <source>Heart</source>
          <year>2013</year>
          <volume>99</volume>
          <issue>20</issue>
          <fpage>1535</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="doi">10.1136/heartjnl-2012-302048</pub-id>
          <pub-id pub-id-type="pmid">23503402</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St&#xF6;llberger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Finsterer</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Ischemic stroke in left ventricular noncompaction and celiac disease</article-title>
          <source>Int J Cardiol</source>
          <year>2014</year>
          <volume>176</volume>
          <issue>2</issue>
          <fpage>534</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijcard.2014.07.033</pub-id>
          <pub-id pub-id-type="pmid">25086466</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Udeoji</surname>
              <given-names>DU</given-names>
            </name>
            <name>
              <surname>Philip</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Morrissey</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Phan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schwarz</surname>
              <given-names>ER</given-names>
            </name>
          </person-group>
          <article-title>Left ventricular noncompaction cardiomyopathy: updated review</article-title>
          <source>Ther Adv Cardiovasc Dis</source>
          <year>2013</year>
          <volume>7</volume>
          <issue>5</issue>
          <fpage>260</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="doi">10.1177/1753944713504639</pub-id>
          <pub-id pub-id-type="pmid">24132556</pub-id>
        </element-citation>
      </ref>
      <ref-list id="BSec1">
        <title>Pre-publication history</title>
        <ref id="CR8">
          <mixed-citation publication-type="other">The pre-publication history for this paper can be accessed here: <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2261/15/7/prepub">http://www.biomedcentral.com/1471-2261/15/7/prepub</ext-link></mixed-citation>
        </ref>
      </ref-list>
    </ref-list>
  </back>
</article>
</pmc-articleset>
